Vubotics Net Worth

Vubotics Net Worth Breakdown

  VBTC
The net worth of Vubotics is the difference between its total assets and liabilities. Vubotics' net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Vubotics' assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Vubotics' net worth can be used as a measure of its financial health and stability which can help investors to decide if Vubotics is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Vubotics stock.

Vubotics Net Worth Analysis

Vubotics' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Vubotics' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Vubotics' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Vubotics' net worth analysis. One common approach is to calculate Vubotics' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Vubotics' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Vubotics' net worth. This approach calculates the present value of Vubotics' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Vubotics' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Vubotics' net worth. This involves comparing Vubotics' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Vubotics' net worth relative to its peers.

Enterprise Value

472,226

To determine if Vubotics is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Vubotics' net worth research are outlined below:
Vubotics is way too risky over 90 days horizon
Vubotics has some characteristics of a very speculative penny stock
Vubotics appears to be risky and price may revert if volatility continues
Vubotics has high likelihood to experience some financial distress in the next 2 years
Vubotics currently holds 400 K in liabilities. Vubotics has a current ratio of 0.35, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Vubotics' use of debt, we should always consider it together with its cash and equity.
The entity reported the previous year's revenue of 37 K. Net Loss for the year was (2.65 M) with profit before overhead, payroll, taxes, and interest of 25.27 K.
Vubotics currently holds about 592.21 K in cash with (1.61 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Vubotics has a frail financial position based on the latest SEC disclosures

Follow Vubotics' market capitalization trends

The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.85 M.

Market Cap

40.78

Project Vubotics' profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(5.61)(5.89)
Return On Capital Employed(3.21)(3.05)
Return On Assets(5.61)(5.89)
Return On Equity 1.24  0.94 
When accessing Vubotics' net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Vubotics' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Vubotics' profitability and make more informed investment decisions.
Please note, the presentation of Vubotics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Vubotics' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Vubotics' management manipulating its earnings.

Evaluate Vubotics' management efficiency

Vubotics has return on total asset (ROA) of (1.8046) % which means that it has lost $1.8046 on every $100 spent on assets. This is way below average. Vubotics' management efficiency ratios could be used to measure how well Vubotics manages its routine affairs as well as how well it operates its assets and liabilities. As of August 25, 2025, Return On Tangible Assets is expected to decline to -5.89. The current year's Return On Capital Employed is expected to grow to -3.05. The current year's Total Current Assets is expected to grow to about 622.2 K, whereas Total Assets are forecasted to decline to about 347.7 K.
Last ReportedProjected for Next Year
Book Value Per Share(0.05)(0.05)
Tangible Book Value Per Share(0.05)(0.05)
Enterprise Value Over EBITDA(0.16)(0.17)
Enterprise Value Multiple(0.16)(0.17)
Enterprise Value529.6 K472.2 K
Understanding the operational decisions made by Vubotics management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Enterprise Value Revenue
68.0472
Revenue
25.3 K
Quarterly Revenue Growth
(0.99)

Vubotics Earnings per Share Projection vs Actual

When determining whether Vubotics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vubotics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vubotics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vubotics Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vubotics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.
For information on how to trade Vubotics Stock refer to our How to Trade Vubotics Stock guide.
You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vubotics. If investors know Vubotics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vubotics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Revenue Growth
(0.99)
Return On Assets
(1.80)
The market value of Vubotics is measured differently than its book value, which is the value of Vubotics that is recorded on the company's balance sheet. Investors also form their own opinion of Vubotics' value that differs from its market value or its book value, called intrinsic value, which is Vubotics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vubotics' market value can be influenced by many factors that don't directly affect Vubotics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vubotics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vubotics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vubotics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.